Diagnosis
Economics
Harm/
aetiology
Prognosis
Therapy
|
|
-
Atrial fibrillation
- persistent: DC cardioversion followed by amiodarone maintenance was most cost-effective
-
| Level of evidence 1b |
Expiry Date November 2003 |
-
Atrial fibrillation
- cardioversion and aspirin, followed by warfarin if AF recurred, was most cost-effective.
-
| Level of evidence 2b |
Expiry Date November
2003 |
-
Atrial fibrillation
- warfarin was more cost-effective than aspirin at preventing stroke in patients with one or more other risk factors
-
| Level of evidence 1b |
Expiry Date November
2003 |
-
Supraventricular tachycardia
- starting antiarrhythmics in hospital was more effective than as an outpatient
-
| Level of evidence 1b |
Expiry Date October 2004 |
|